Trends in survival from muscular dystrophy in England and Wales and impact on respiratory services

被引:25
作者
Calvert, LD
McKeever, TM
Kinnear, WJM
Britton, JR
机构
[1] Univ & City Hosp, Nottingham Assisted Ventilat Grp, Nottingham NG7 2UH, England
[2] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England
关键词
Duchenne muscular dystrophy; mortality trends; muscular dystrophy; non-invasive ventilation; respiratory failure; survival;
D O I
10.1016/j.rmed.2005.09.030
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Respiratory failure is an important terminal event in muscular dystrophy, but increasingly is effectively treated by non-invasive ventilation. This study was designed to assess mortality statistics in this patient group in order to get an indication of future demand. Mortality data for all deaths from muscular dystrophy registered by death certification in England and Wales between 1993 and 1999 were analysed. In total, 817 deaths from muscular dystrophy were registered between 1993 and 1999. Annual number of deaths was unchanged over this period. Median age at death (interquartile range) for all cause muscular dystrophy increased from 20 (17-42.5) years in 1993, to 26 (17.5-63) years in 1999. Respiratory failure was the primary or contributory cause of death in 82% of cases. Two thirds of these deaths were during acute infection. We can expect 100 patients with muscular dystrophy to develop respiratory failure in England and Wales each year, so non-invasive ventilation services probably need to be able to provide for 0.2 new patients per 100,000 population annually. Respiratory services also need to provide adequate monitoring and early treatment of infection in these patients. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1058 / 1063
页数:6
相关论文
共 13 条
[1]
ADAMS AB, 1998, RESP CARE, V43, P635
[2]
ADAMS AB, 1993, CHEST, V103, P463
[3]
BAROIS A, 1993, EUR RESPIR REV, V3, P275
[4]
Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation [J].
Eagle, M ;
Baudouin, SV ;
Chandler, C ;
Giddings, DR ;
Bullock, R ;
Bushby, K .
NEUROMUSCULAR DISORDERS, 2002, 12 (10) :926-929
[5]
Long-term ventilation for patients with Duchenne muscular dystrophy - Physicians' beliefs and practices [J].
Gibson, B .
CHEST, 2001, 119 (03) :940-946
[6]
Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey [J].
Lloyd-Owen, SJ ;
Donaldson, GC ;
Ambrosino, N ;
Escarabill, J ;
Farre, R ;
Fauroux, B ;
Robert, D ;
Schoenhofer, B ;
Simonds, AK ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (06) :1025-1031
[7]
Rideau Y, 1983, Acta Neurol (Napoli), V5, P118
[8]
Noninvasive ventilation for chest wall and neuromuscular disorders [J].
Shneerson, JM ;
Simonds, AK .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (02) :480-487
[9]
Simonds A K, 2000, Monaldi Arch Chest Dis, V55, P237
[10]
Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy [J].
Simonds, AK ;
Muntoni, F ;
Heather, S ;
Fielding, S .
THORAX, 1998, 53 (11) :949-952